Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › GREENFIELD › BAYSTATE FRANKLIN MEDICAL CENTER

BAYSTATE FRANKLIN MEDICAL CENTER

NPI: 1508867391 · GREENFIELD, MA 01301 · General Acute Care Hospital · NPI assigned 08/03/2005

$29.11M
Total Medicaid Paid
810,833
Total Claims
687,973
Beneficiaries
316
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMCCARTHY, RAYMOND (SR VP, CFO & TREAS, BAYSTATE HEALTH)
NPI Enumeration Date08/03/2005

Related Entities

Other providers sharing the same authorized official: MCCARTHY, RAYMOND

ProviderCityStateTotal Paid
BAYSTATE MEDICAL CENTER INC SPRINGFIELD MA $40.55M
BAYSTATE WING HOSPITAL CORPORATION PALMER MA $38.22M
BAYSTATE WING HOSPITAL CORPORATION PALMER MA $2.29M
BAYSTATE MEDICAL CENTER INC SPRINGFIELD MA $1.12M
BAYSTATE FRANKLIN MEDICAL CENTER GREENFIELD MA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 133,145 $4.41M
2019 128,272 $3.44M
2020 100,103 $2.55M
2021 108,962 $3.27M
2022 118,676 $4.47M
2023 136,137 $5.71M
2024 85,538 $5.25M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 44,716 38,860 $4.67M
99283 Emergency department visit for the evaluation and management, moderate severity 33,560 29,984 $3.56M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 32,529 28,807 $3.46M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 18,831 15,692 $2.84M
96361 Intravenous infusion, hydration; each additional hour 8,723 6,767 $2.15M
41899 Unlisted procedure, dentoalveolar structures 714 676 $1.22M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,285 1,251 $671K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,198 5,868 $626K
74177 Computed tomography, abdomen and pelvis; with contrast material 5,428 5,111 $587K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 11,189 4,329 $552K
S9485 Crisis intervention mental health services, per diem 1,212 861 $531K
70450 Computed tomography, head or brain; without contrast material 4,968 4,588 $467K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4,372 3,742 $421K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,978 1,245 $262K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 9,142 7,530 $253K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1,814 803 $238K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 8,487 7,137 $237K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4,357 3,658 $215K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 1,405 1,292 $210K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1,298 1,086 $207K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,575 1,511 $195K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,216 2,111 $193K
71275 Computed tomographic angiography, chest, with contrast material 1,029 989 $174K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,344 1,309 $165K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 41,653 33,219 $165K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,057 1,819 $163K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 978 976 $162K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1,931 710 $161K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,609 1,559 $155K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 908 906 $152K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 963 915 $150K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 4,839 1,942 $147K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 6,342 4,490 $142K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,765 4,324 $142K
76830 Ultrasound, transvaginal 1,483 1,444 $132K
77063 Screening digital breast tomosynthesis, bilateral 2,599 2,559 $119K
93971 788 753 $118K
G0378 Hospital observation service, per hour 3,772 3,449 $116K
87631 1,725 1,665 $116K
97161 2,365 2,242 $113K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 7,574 6,338 $111K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 683 683 $107K
71046 Radiologic examination, chest; 2 views 10,696 9,948 $107K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6,631 5,657 $101K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,088 1,867 $97K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 169 161 $78K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 547 542 $73K
84484 11,594 9,431 $63K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,372 1,262 $63K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 471 464 $63K
84702 6,038 5,368 $62K
45380 Colonoscopy, flexible; with biopsy, single or multiple 143 135 $61K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 12,404 10,864 $60K
96375 Therapeutic injection; each additional sequential IV push 10,816 8,519 $47K
83880 3,370 3,071 $47K
77067 Screening mammography, bilateral, including computer-aided detection 2,784 2,740 $47K
83605 7,979 7,077 $46K
97162 983 932 $45K
84443 Thyroid stimulating hormone (TSH) 5,856 5,417 $45K
83690 10,955 9,634 $41K
ATP14 5,599 4,148 $41K
12001 274 262 $39K
99215 Prolong outpt/office vis 258 223 $36K
ATP07 5,236 4,201 $35K
93975 425 408 $29K
97035 699 300 $29K
71250 654 628 $29K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,208 1,176 $28K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,195 1,163 $28K
80053 Comprehensive metabolic panel 12,023 10,341 $27K
87040 4,367 2,721 $27K
ATP08 4,728 3,573 $27K
81025 5,100 4,689 $27K
94060 383 367 $27K
76642 303 291 $25K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,411 2,229 $25K
ATP11 3,400 2,687 $24K
G0297 Low dose ct scan (ldct) for lung cancer screening 259 258 $24K
83735 6,659 5,342 $22K
73630 1,618 1,555 $21K
87086 Culture, bacterial; quantitative colony count, urine 4,542 4,178 $21K
V5266 Battery for use in hearing device 303 290 $20K
86850 3,156 2,940 $20K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 18,109 15,679 $19K
87088 2,225 1,818 $18K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 54 52 $17K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 459 420 $16K
70496 186 173 $16K
93017 274 268 $16K
85027 4,893 4,092 $16K
94727 430 415 $16K
76770 108 107 $15K
85379 2,586 2,451 $14K
73130 1,023 962 $14K
81001 8,024 7,242 $14K
92567 505 495 $14K
73030 1,093 1,039 $13K
J2405 Injection, ondansetron hydrochloride, per 1 mg 11,093 9,579 $13K
73560 1,285 1,197 $13K
73610 1,221 1,154 $12K
72125 Computed tomography, cervical spine; without contrast material 1,564 1,434 $12K
90460 Immunization administration through 18 years of age via any route, first or only component 2,177 2,147 $12K
80048 Basic metabolic panel (calcium, ionized) 10,755 9,264 $11K
86780 1,081 1,050 $11K
0002A 429 408 $11K
0001A 459 439 $11K
71271 615 589 $11K
80051 19,588 15,979 $10K
92557 194 189 $10K
85610 6,074 4,777 $10K
90715 835 822 $10K
J3010 Injection, fentanyl citrate, 0.1 mg 5,089 4,791 $9K
72100 484 466 $9K
71045 Radiologic examination, chest; single view 4,580 4,176 $9K
87340 1,093 1,055 $9K
J2704 Injection, propofol, 10 mg 5,955 5,602 $9K
83036 Hemoglobin; glycosylated (A1C) 2,219 2,155 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,837 3,523 $8K
J1885 Injection, ketorolac tromethamine, per 15 mg 7,530 6,552 $8K
81015 5,049 4,491 $8K
87081 1,608 1,444 $8K
90791 Psychiatric diagnostic evaluation 52 52 $8K
76801 127 113 $7K
94729 387 374 $7K
59025 Fetal non-stress test 26 15 $7K
74018 229 210 $7K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 164 149 $7K
86140 2,380 2,078 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,847 1,703 $7K
73110 467 429 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 364 351 $6K
73502 479 455 $6K
86900 3,142 2,935 $6K
86901 3,142 2,935 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination 3,842 3,565 $6K
82565 20,744 16,953 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 420 404 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 46 43 $5K
82947 16,433 14,218 $5K
87186 1,128 1,069 $5K
81513 61 59 $5K
86762 368 353 $4K
76942 28 27 $4K
87070 725 674 $4K
90686 837 825 $4K
85730 1,509 1,396 $4K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 203 200 $4K
84520 19,891 16,515 $4K
97012 95 39 $4K
29125 27 26 $4K
84439 868 830 $4K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 28 15 $4K
82728 544 499 $4K
ATP10 641 546 $4K
J0690 Injection, cefazolin sodium, 500 mg 1,233 1,064 $3K
93970 26 26 $3K
90633 209 209 $3K
86803 340 329 $3K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 146 143 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,402 1,313 $3K
85652 2,010 1,779 $3K
ATP17 463 428 $3K
ATP15 457 323 $3K
ATP06 406 305 $2K
90834 Psychotherapy, 45 minutes with patient 26 25 $2K
84460 9,433 8,142 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 102 68 $2K
90480 47 47 $2K
73140 94 90 $2K
84450 9,227 7,964 $2K
94618 16 14 $2K
96415 16 13 $2K
82607 345 339 $2K
83655 163 162 $2K
J1170 Injection, hydromorphone, up to 4 mg 2,172 1,474 $2K
95806 12 12 $2K
J2270 Injection, morphine sulfate, up to 10 mg 2,814 2,183 $2K
ATP09 263 204 $2K
87147 435 399 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 13 13 $2K
93308 13 13 $2K
90651 304 304 $2K
36415 Collection of venous blood by venipuncture 39,853 32,503 $2K
12011 12 12 $2K
86618 170 162 $2K
87481 63 59 $2K
J1650 Injection, enoxaparin sodium, 10 mg 353 223 $2K
87205 555 511 $1K
90677 279 278 $1K
87522 Neg quan hep c or qual rna 44 44 $1K
J3490 Unclassified drugs 1,067 768 $1K
90675 23 13 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 67 65 $1K
82247 7,839 6,782 $1K
87077 624 577 $1K
84075 7,197 6,339 $1K
90656 78 78 $1K
81003 1,021 931 $1K
86003 26 26 $1K
82570 429 404 $1K
76819 Fetal biophysical profile; without non-stress testing 28 14 $1K
ATP02 345 308 $1K
Q3014 Telehealth originating site facility fee 473 440 $963.45
77065 Tomosynthesis, mammo 42 40 $953.74
ATP03 397 338 $870.55
84153 96 92 $815.28
J1630 Injection, haloperidol, up to 5 mg 890 752 $789.78
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,776 1,391 $788.64
0124A 32 32 $779.79
97803 12 12 $765.50
83550 137 126 $739.83
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3,853 3,428 $734.90
96367 37 28 $698.13
83540 174 162 $693.93
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 40 37 $669.18
51798 484 476 $655.82
80061 Lipid panel 2,057 2,008 $652.04
70486 24 24 $637.50
73562 25 25 $630.32
J0696 Injection, ceftriaxone sodium, per 250 mg 778 636 $593.11
76536 13 13 $564.80
90474 354 353 $547.64
70498 184 171 $537.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 19 15 $514.59
82746 74 72 $506.67
ATP12 73 55 $502.20
80164 104 92 $492.81
77080 27 27 $464.94
73590 26 25 $425.81
72110 13 12 $413.45
J2060 Injection, lorazepam, 2 mg 2,463 1,968 $400.03
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 15 14 $369.20
83516 34 29 $367.62
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 38 35 $325.00
97597 16 12 $281.76
86704 39 37 $274.75
90714 15 14 $269.38
90670 273 272 $253.80
73080 17 16 $237.09
82043 123 121 $233.36
80076 928 857 $229.24
87476 15 13 $216.65
82784 30 30 $214.48
J3370 Injection, vancomycin hcl, 500 mg 130 80 $202.72
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 9,832 8,751 $186.07
82550 940 830 $176.16
80178 48 44 $170.50
90674 13 13 $163.92
85018 86 80 $156.75
82010 46 41 $154.21
94664 499 448 $149.44
J0131 Injection, acetaminophen, not otherwise specified,10 mg 85 85 $141.47
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 277 225 $141.47
91320 12 12 $131.10
86038 15 15 $124.60
86706 14 14 $118.69
J3475 Injection, magnesium sulfate, per 500 mg 119 99 $100.07
ATP16 17 16 $98.01
96376 4,682 3,194 $93.06
90734 51 51 $86.82
90671 28 28 $86.82
82950 13 13 $63.57
86308 13 12 $58.74
84156 20 15 $52.78
82800 13 13 $48.78
J0171 Injection, adrenalin, epinephrine, 0.1 mg 74 70 $45.73
ATP04 15 12 $43.44
J1644 Injection, heparin sodium, per 1000 units 147 79 $42.38
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 162 161 $27.02
82962 5,826 3,781 $25.63
84100 976 767 $9.19
90662 70 70 $6.03
83615 114 88 $5.33
82310 94 76 $5.33
90839 48 43 $2.96
Q0247 Injection, sotrovimab, 500 mg 24 15 $0.01
90723 367 365 $0.00
94760 566 421 $0.00
94644 491 442 $0.00
90696 12 12 $0.00
90680 288 287 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 112 104 $0.00
90697 30 30 $0.00
82040 224 193 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 250 233 $0.00
G0008 Administration of influenza virus vaccine 257 255 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 57 50 $0.00
70320 15 14 $0.00
90632 12 12 $0.00
90716 37 37 $0.00
88304 12 12 $0.00
87478 14 12 $0.00
90619 12 12 $0.00
87468 14 12 $0.00
82248 229 195 $0.00
70310 99 99 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 315 285 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 38 36 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 162 134 $0.00
90710 50 50 $0.00
90648 537 536 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 468 438 $0.00
80143 248 227 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 89 76 $0.00
87469 14 12 $0.00
80179 161 151 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 517 462 $0.00
90461 204 203 $0.00
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 97 90 $0.00
84155 79 65 $0.00
91308 18 16 $0.00
84550 33 27 $0.00
91300 520 466 $0.00
90700 29 29 $0.00
90707 26 26 $0.00
J1171 Injection, hydromorphone, 0.1 mg 20 14 $0.00